Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Cannabis company Cronos Group Inc. (NASDAQ:CRON)  announced last week that it had to delay filing third-quarter earnings due to pending impairment charges for its U.S. CBD activities.  The Toronto-based company was unable to file its quarterly report saying that its audit committee needed more time to evaluate goodwill and indefinite-lived intangible assets in its U.S. reporting unit for impairment.

Cronos Stock Continues To Dive After Earnings Report Delay, BofA Lowers Price Target

Canopy Growth

Tilray Brands

Barclays analyst Guarav Jain on Thursday initiated coverage of three cannabis stocks but said their businesses are limited by the relatively small size of the legal market in Canada. Barclays launched overage of Tilray TLRY, -4.86% and Cronos CRON, -4.48% with an underweight rating and price targets of $10 and $5.50 respectively.

Barclays initiates coverage of Tilray, Cronos and Canopy Growth

Meet Cron, a new calendar app for the Mac that wants to bring some innovation to this space. The startup directly mentions Sunrise as an inspiration for those of you who still remember it.

Cron is a new calendar app following in Sunrise's footsteps

San Francisco, California--(Newsfile Corp. - November 16, 2021) -  Hagens Berman urges Cronos Group Inc. (NASDAQ: CRON) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.Visit: www.hbsslaw.com/investor-fraud/CRON Contact An Attorney Now: CRON@hbsslaw.com 844-916-0895Cronos Group Inc. (CRON) Investigation: In past quarters Cronos has maintained it reports its financial results in accordance with...

CRON INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm's Attorneys, Firm Investigating Cronos' Admitted Improper Accounting

Los Angeles, California--(Newsfile Corp. - November 15, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or "the Company") (NASDAQ: CRON) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9,...

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

Aurora Cannabis

Agrify

Colgate-Palmolive

Clever Leaves Holdings Inc

GrowGeneration Corp

HEXO Corp

InMed Pharmaceuticals

Jazz Pharmaceuticals

Akerna Corp

Urban-gro

Village Farms International

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

This Week's Slew of Cannabis Earnings and Breaking News

LOS ANGELES--(BUSINESS WIRE)---- $CRON #CRON--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

SNDL Inc.

Cronos Group Inc (NASDAQ: CRON) remains in the focus of investors after New Cannabis Ventures reported that the Altria Group Inc (NYSE: MO) could buy the remaining outstanding shares of the cannabis company. Cronos Group shares advanced above $6.7 after this news but, shares have weakened from their recent highs, and the current price stands […] The post What're a better buy?

What're a better buy? Cronos Group or Sundial Growers shares

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The

CRON INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation – CRON

New York, New York--(Newsfile Corp. - November 9, 2021) - Levi & Korsinsky notifies investors that it has commenced an investigation of Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON) concerning possible violations of federal securities laws. On November 9, 2021, Cronos filed a Form 8-K with the SEC in which it disclosed that it had determined the previous day that the Company wou

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Cronos Group Inc.

The cannabis sector has seen an uptick in volume this week, which has helped many of the stocks to begin to rebound after almost a full year of steady decline. High volume indicates a high level of trader and investor interest, which means those who have left the sector may be finding cannabis stocks attractive again.

Aurora, Canopy, Cronos And Tilray: Analyzing Cannabis Stocks For Short Squeeze Potential

Atlanta, Georgia--(Newsfile Corp. - November 9, 2021) -  Holzer & Holzer, LLC is investigating whether Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON) complied with federal securities laws. On November 9, 2021, the Company filed a Form 8-K stating Cronos "will be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021 previously filed on Form 10-Q on August 6, 2021. The Company's financial...

SHAREHOLDER ALERT: Investigation of Cronos Group Inc. Announced by Holzer & Holzer, LLC

The Canadian marijuana company no longer has confidence in its U.S. CBD assets.

Why Cronos Group Is Plunging Today

Cannabis company Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) had to delay filing third-quarter earnings due to pending impairment charge for its U.S. CBD activities. The Toronto-based company revealed Tuesday it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission (SEC) in relation to its quarterly financial report for the period ended September 30, 2021.

Cronos' Shares Plummet On Q3 Financial Report Delay Due To Pending Impairment Charge For U.S. CBD Activities

TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Form 10-Q”).

Cronos Group Files Form 12b-25

Renewed legalization efforts could spark a wave of acquisitions.

Why Cronos Group, Tilray, Sundial Growers, and Other Cannabis Stocks Soared Today

Cronos Group Inc (NASDAQ:CRON) is trading higher Monday following reports of a Republican-led marijuana legalization bill. According to reports from Marijuana Moment, the bill is a compromise between simple descheduling as proposed by other Republican lawmakers and wide-ranging legislation proposed by Democratic lawmakers.

Why Cronos Group Shares Are Moving Higher Today

JP Morgan rescinding news on cannabis stock restriction? GOP's legalization bill treats marijuana like alcohol?

$ACB Expands European Presence; $MSOS Sees Massive Volume Spike — Cannabis Daily November 8, 2021

Altria

Shares of Cronos Group Inc (TSE: CRON) are up more than 20% on Monday after New Cannabis Ventures said Altria Group Inc (NYSE: MO) could buy the remaining outstanding shares of the pot producer as soon as next week. Altria already has a 45% stake in Cronos Group Altria currently has a 45% stake in […] The post Speculation: Altria could buy the balance of Cronos Group appeared first on Invezz.

Speculation: Altria could buy the balance of Cronos Group

Today, news of what could potentially be a big legislative win, as well as the recent infrastructure bill news, is boosting cannabis stocks. The post Cannabis Stocks: Why TLRY, CRON, ACB, SNDL Stocks Are Getting High Today appeared first on InvestorPlace.

Cannabis Stocks: Why TLRY, CRON, ACB, SNDL Stocks Are Getting High Today

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cannabis stocks posted big gains Monday amid optimism about M&A and federal legalization in a rare burst of energy in the sector that's been trading mostly lower this year.

Cannabis Watch: Cannabis stocks rally on talk of M&A and latest moves toward possible reform of federal ban

Cronos Group Strategic Investor Altria May Be About To Buy The Balance

Cannabis marketplace Leafly Holdings, Inc. released its inaugural Cannabis Harvest Report on Wednesday revealing that cannabis is America's 5th most valuable crop. The report takes the first look at cannabis data, insights and projections across the 11 states where Americans can currently purchase both adult-use and medical cannabis.

Report: Cannabis Is America's 5th Most Valuable Crop, Earning More For Farmers Than Cotton Or Rice

JPMorgan Chase & Co has told prime brokerage clients it will no longer let them buy U.S. cannabis-related securities beginning Nov. 8, according to a letter seen by Reuters.

Exclusive-JPMorgan to restrict trading of U.S. cannabis stocks -letter

Arye Weigensberg Named Interim Head of Research and Development

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

News for Cronos Group Stock (CRON)